Prognosis
Fear of Vial Shortage for Covid Vaccines Prompts Flurry of Deals
- CEPI secures production for 100 million multidose glass vials
- Move follows similar deals made by companies, U.S. government
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Fears that a shortage of glass vials could hinder efforts to quickly deploy a Covid-19 vaccine are prompting a flurry of deals to clinch the in-demand containers.